Stocks/EXEL

Create a free account to see ACCE Scores

Sign up for free to unlock scores, score breakdowns, and stock analysis.

EXEL

↓ PDF (Pro)
Exelixis Inc. Common Stock
HealthcareBiotechnologyUnited StatesNASDAQ
$48.43
+9.03%today
MKT CAP
$12.3B
+5.9% · 1Y
Earnings History
+16.2%
+16.2%
+16.2%
+14.0%
Q2 '25
Q3 '25
Q4 '25
Q1 '26
Analyst Targets
Current price
$48.43
Low
$35.00
Analyst Mean
$48.06
High
$60.00
17 analystsBuy
Full Financials
Trailing P/E15.3x
Forward P/E11.5x
EV/EBITDA-
Price/Sales-
Dividend Yield-
Revenue Growth YoY-
Earnings Growth YoY-
Revenue Growth QoQ+2.0%
5y Revenue CAGR+12.9%
5y Earnings CAGR+62.5%
Gross Margin-
Operating Margin-
Net Margin-
ROE-
Debt / Equity-
Free Cash Flow-
Insider Ownership2.0%
Institutional Ownership106.5%
Short % of Float15.10%
Days to Cover11.9d
1 Week-1.3%
1 Month-
3 Months-
6 Months-
YTD-
1 Year-
3 Years-
5 Years-
vs 50-day SMA-
vs 200-day SMA-
vs 52w High-
vs 52w Low-
Insider Transactions
FilerRoleTypeSharesPriceValueDate
MORRISSEY MICHAEL MChief Executive OfficerStock160,437$0.00$0.00M2026-02-26
SENNER CHRISTOPHER J.Chief Financial OfficerStock52,018$0.00$0.00M2026-02-26
HALEY PATRICK JOSEPHOfficerStock40,459$0.00$0.00M2026-02-26
AFTAB T DANAOfficerStock52,018$0.00$0.00M2026-02-26
HEFTI BRENDAGeneral CounselStock23,119$0.00$0.00M2026-02-26
Top Holders
HolderType% HeldValueΔ SharesAs of
Blackrock Inc.institution11.89%$1.47B+2.84%2025-12-31
Vanguard Group Incinstitution10.04%$1.24B-2.20%2025-12-31
Farallon Capital Management LLCinstitution6.18%$0.76B-19.44%2025-12-31
Renaissance Technologies, LLCinstitution5.48%$0.68B-10.00%2025-12-31
AQR Capital Management, LLCinstitution5.38%$0.66B+48.76%2025-12-31
State Street Corporationinstitution4.13%$0.51B-5.61%2025-12-31
iShares Trust-iShares Core S&P Mid-Cap ETFfund3.39%$0.42B-0.56%2026-03-31
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fundfund3.17%$0.39B+0.18%2025-12-31
Fuller & Thaler Asset Management Inc.institution3.13%$0.39B-4.33%2025-12-31
LSV Asset Managementinstitution3.05%$0.38B-0.29%2025-12-31
Geode Capital Management, LLCinstitution2.96%$0.37B-1.85%2025-12-31
Capitol Series Trust-FullerThaler Behavioral Small-Cap Equity Fundfund2.67%$0.33B-6.93%2025-12-31
Invesco Ltd.institution2.38%$0.29B+1.58%2025-12-31
VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fundfund2.28%$0.28B-4.65%2025-12-31
VANGUARD INDEX FUNDS-Vanguard Small-Cap Growth Index Fundfund1.28%$0.16B-3.88%2025-12-31
VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fundfund1.14%$0.14B+0.33%2025-12-31
Invesco Exchange-Traded Fund Trust-Invesco S&P MidCap Quality ETFfund0.99%$0.12B-1.22%2026-03-31
SPDR SERIES TRUST-State Street SPDR S&P Biotech ETFfund0.84%$0.10B-10.47%2026-03-31
SPDR S&P MIDCAP 400 ETF TRT-State Street SPDR S&P Mid Cap 400 ETF TRTfund0.77%$0.09B-0.42%2026-03-31
iShares Trust-iShares Biotechnology ETFfund0.74%$0.09B-3.47%2026-03-31
TickerCapScoreP/EFwd P/EEV/EBITDAROEGrossD/EDiv
MDGL
Madrigal Pharmaceuticals Inc. Common Stock
$12.4B20-42.3----0.00%
IONS
Ionis Pharmaceuticals Inc. Common Stock
$12.7B41----67.6%11%531.050.00%
AXSM
Axsome Therapeutics Inc. Common Stock
$11.4B49-37.4--349.4%93%402.840.00%
BBIO
BridgeBio Pharma Inc. Common Stock
$13.4B52-128.7--96%-0.00%
SMMT
Summit Therapeutics Inc. Common Stock
$13.8B5------0.00%
ARWR
Arrowhead Pharmaceuticals Inc. Common Stock
$11.0B1249.5-----0.00%
Peers selected by sector + industry + nearest market cap. Best in column highlighted green, worst red.
Unlock Full Financials
Growth metrics, valuation multiples, and profitability ratios on Starter+.
Upgrade from $15/mo →
Growth73Value58Quality82Momentum61Total80
Score breakdown on Starter+
Upgrade →
Score History (90d)
Pro onlyUpgrade →
Updated 5/8/2026
Recent Alerts
No alerts yet for EXEL.
Want deep analysis?
This stock isn't in the ACCE researched universe. Browse 300+ stocks with full thesis, scores, and financial models.
Browse ACCE Indices →
Get the ACCE weekly digest
Index returns, picks recap, score movers - every Sunday. No fluff.